fbpx
Category Cardiology
CCC Critical Care compendium 340

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders (affecting ~ 1 in 500 people) and is the number one cause of sudden cardiac death in young athletes. Annual mortality is estimated at 1-2 %.
CCC Critical Care compendium 340

Heart Failure Literature Summaries

Follath F, et al; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002 Jul…

CCC Critical Care compendium 340

Nasal intubation

nasal intubation may be performed blind or with fiberoptic assistance. Indicated when oral intubation is not feasible
CCC Critical Care compendium 340

Cardiac Output

Cardiac Output (CO) = Stroke Volume (SV) x Heart rate (HR) CO = SV x HR changes based on exercise, age and body size. normal adult = 5L/min Stroke Volume (SV) determined by: Preload Afterload Contractility

CCC Critical Care compendium 340

Cardiac Biomarkers

Biomarkers can potentially be used to detect and monitor a wide range of cardiac conditions in the critical care setting
CCC Critical Care compendium 340

Cardiac Arrest Literature Summaries

THERAPEUTIC HYPOTHERMIA AND TARGETED TEMPERATURE MANAGEMENT Nielsen N, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. [PMID 24237006] MCRCT without allocation concealment 36 ICUs in Europe and Australia n…

CCC Critical Care compendium 340

Beta Blockers to Prevent Perioperative MI

The use of Beta-blockers in perioperative medicine has been an issue of intense research in Anaesthesia. Patients that are believed to benefit from beta-blockers are those with risk factors for ischaemic heart disease (HT, DM, hypercholesterolaemia, previous MI, angina, controlled heart failure)
CCC Critical Care compendium 340

Atrial Natriuretic Peptide

Atrial Natriuretic Peptide isolated from the right atrium potent diuretic/natriuretic effect on kidney + vasodilator effects on resistance & capacitance of blood vessels released in response to atrial stretching (ie. fluid overload)
CCC Critical Care compendium 340

Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained dysrhythmia and is characterised by disorganised atrial electrical activity and contraction resulting in an "irregularly irregular" ventricular response ("fibrillation waves")